TSX News -
Medicenna Presents Preclinical Data on MDNA11 and Bizaxofusp at the 2024 Annual Meeting of the Society for Neuro-Oncology (SNO)
MDNA11 shows significant survival benefits in preclinical glioblastoma models, expanding CD8+T and NK cells Bizaxofusp selectively targets human tumor cells […]